Fingerprint
Dive into the research topics of 'A phase II, multicenter, open-label randomized study of motesanib or bevacizumab in combination with paclitaxel and carboplatin for advanced nonsquamous non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically